Metipranolol
Systematic (IUPAC) name | |
---|---|
(RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate | |
Clinical data | |
Trade names | Optipranolol |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601078 |
Identifiers | |
CAS Number | 22664-55-7 |
ATC code | S01ED04 (WHO) C07BA68 |
PubChem | CID 31477 |
IUPHAR/BPS | 7239 |
DrugBank | DB01214 |
ChemSpider | 29193 |
UNII | X39AL81KEB |
KEGG | D02374 |
ChEMBL | CHEMBL1291 |
Chemical data | |
Formula | C17H27NO4 |
Molar mass | 309.401 g/mol |
Chirality | Racemic mixture |
| |
| |
(verify) |
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
References
- ↑ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series 4 (6): 217–223.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.